Show simple item record

dc.contributor.authorCarabin, Hélène
dc.contributor.authorBalsera-Rodríguez, Francisco J
dc.contributor.authorRebollar-Sáenz, José
dc.contributor.authorBenner, Christine T
dc.contributor.authorBenito, Aitziber
dc.contributor.authorFernández-Crespo, Juan C
dc.contributor.authorCarmena, David 
dc.date.accessioned2018-12-19T10:47:58Z
dc.date.available2018-12-19T10:47:58Z
dc.date.issued2014-08-07
dc.identifier.citationPLoS Negl Trop Dis. 2014 Aug 7;8(8):e3069.es_ES
dc.identifier.issn1935-2735es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/6900
dc.description.abstractCystic echinococcosis (CE) is endemic in Spain but has been considered non-endemic in the province of Álava, Northern Spain, since 1997. However, Álava is surrounded by autonomous regions with some of the highest CE prevalence proportions in the nation, casting doubts about the current classification. The purpose of this study is to estimate the frequency of CE in humans and animals and to use this data to determine the societal cost incurred due to CE in the Álava population in 2005. We have identified epidemiological and clinical data from surveillance and hospital records, prevalence data in intermediate (sheep and cattle) host species from abattoir records, and economical data from national and regional official institutions. Direct costs (diagnosis, treatment, medical care in humans and condemnation of offal in livestock species) and indirect costs (productivity losses in humans and reduction in growth, fecundity and milk production in livestock) were modelled using the Latin hypercube method under five different scenarios reflecting different assumptions regarding the prevalence of asymptomatic cases and associated productivity losses in humans. A total of 13 human CE cases were reported in 2005. The median total cost (95% credible interval) of CE in humans and animals in Álava in 2005 was estimated to range between €61,864 (95%CI%: €47,304-€76,590) and €360,466 (95%CI: €76,424-€752,469), with human-associated losses ranging from 57% to 93% of the total losses, depending on the scenario used. Our data provide evidence that CE is still very well present in Álava and incurs important cost to the province every year. We expect this information to prove valuable for public health agencies and policy-makers, as it seems advisable to reinstate appropriate surveillance and monitoring systems and to implement effective control measures that avoid the spread and recrudescence of the disease.es_ES
dc.description.sponsorshipThe authors received no specific funding for this study.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library of Sciencees_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAnimals es_ES
dc.subject.meshCattle es_ES
dc.subject.meshCattle Diseases es_ES
dc.subject.meshEchinococcosis es_ES
dc.subject.meshHumans es_ES
dc.subject.meshLivestock es_ES
dc.subject.meshPrevalence es_ES
dc.subject.meshPublic Health es_ES
dc.subject.meshSheep es_ES
dc.subject.meshSheep Diseases es_ES
dc.subject.meshSpain es_ES
dc.subject.meshCost of Illness es_ES
dc.titleCystic echinococcosis in the Province of Álava, North Spain: the monetary burden of a disease no longer under surveillancees_ES
dc.typeArtículoes_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID25102173es_ES
dc.format.volume8es_ES
dc.format.number8es_ES
dc.format.pagee3069es_ES
dc.identifier.doi10.1371/journal.pntd.0003069es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1935-2735es_ES
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pntd.0003069es_ES
dc.identifier.journalPLoS neglected tropical diseaseses_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional